AdAPT-002

N/A

Report date: 2025/01/26 18:49:51

Base Information

Drug NameAdAPT-002
Drug Alias NameAdAPT-002 (EpiCentrx)oncolytic adenovirus therapy (EpicentRx)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEpicentrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpicentrx Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A